Dr. Priyanka Ingle
Translational Clinical Pharmacologist, CRC Pharma LLC, USA
With over 10 years of translational research experience involving clinical and laboratory studies, Dr. Ingle-Jadhav leads scientific innovation at CRC Pharma LLC. Her role is prudent in representing and implementing company’s strategic vision and pioneering innovation by devising complementary alliances. As a Clinical-Regulatory expert Dr. Ingle-Jadhav consults for early stage transition of molecules and devices, and supports during their regulatory pathways. Dr. Ingle-Jadhav is involved in devising and implementing of CRC Pharma’s perspective for Business and Clinical Regulatory Services.
Her role is crucial in integration of subject matter expertise for generating novel product concepts, supporting drug development programs, liaising with partners and commercialization of technologies. Dr. Ingle-Jadhav is a Physician-Researcher specializing in Pharmaceutical Medicine, Clinical Pharmacology. One of the major areas of her research focuses on Complementary and Integrative Health Medicine involving both lab and clinical methods. She brings in expertise of diverse therapeutic areas like infectious diseases, immunology-autoimmune diseases, pathology, dermatology, diabetes and domains like Outcome research focusing on HRQOL studies.
Dr. Ingle-Jadhav, received her medical degree and PhD in Pharmaceutical Medicine from State Health University, Mumbai, India and postdoctoral training at UF diabetes institute, University of Florida, Gainesville, Florida. She has published several peer reviewed research articles in reputed research journals, co-edited a book, authored chapters in books, presented at national and international conferences, won many awards and also contribute as associate editor to the Journal of Ayurveda and Integrative Medicine.